Effects of SGLT2 Inhibitors on Islet Cell Function and Insulin Sensitivity in Patients of Type 2 Diabetes Mellitus
Condition:   Type 2 Diabetes Mellitus Interventions:   Drug: Dapagliflozin;   Drug: Empagliflozin;   Drug: Canagliflozin Sponsor:   Peking Union Medical College Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 10, 2019 Category: Research Source Type: clinical trials

Replication of the CANVAS Diabetes Trial in Healthcare Claims
Condition:   Diabetes Interventions:   Drug: Canagliflozin;   Drug: DPP-4 inhibitor Sponsor:   Brigham and Women's Hospital Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 3, 2019 Category: Research Source Type: clinical trials